ACME Lithium Inc.
ACLHF
$0.0171
-$0.0029-14.50%
| Weiss Ratings | ACLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | ACLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | ACLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.60 | |||
| Price History | ACLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -9.52% | |||
| 30-Day Total Return | -25.33% | |||
| 60-Day Total Return | -30.49% | |||
| 90-Day Total Return | -57.25% | |||
| Year to Date Total Return | -25.00% | |||
| 1-Year Total Return | -61.31% | |||
| 2-Year Total Return | -95.11% | |||
| 3-Year Total Return | -98.12% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -71.50% | |||
| 52-Week Low % Change | 13.25% | |||
| Price | ACLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.06 | |||
| 52-Week Low Price | $0.02 | |||
| 52-Week Low Price (Date) | Mar 04, 2025 | |||
| 52-Week High Price (Date) | Mar 20, 2024 | |||
| Valuation | ACLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.58M | |||
| Enterprise Value | 1.60M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -55.98% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.15 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.02 | |||
| Enterprise Value/EBITDA (TTM) | -3.28 | |||
| Enterprise Value/EBIT | -3.16 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ACLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 75.97M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ACLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 604 564 9045 | |||
| Address | 318-1199 West Pender St Vancouver, BC V6E 2R1 | |||
| Website | acmelithium.com | |||
| Country | Canada | |||
| Year Founded | 2017 | |||
| Profitability | ACLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | ACLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -3.36% | |||
| Return on Equity | -- | |||
| Income Statement | ACLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -487.60K | |||
| EBIT (TTM) | -506.40K | |||
| Net Income (TTM) | -584.90K | |||
| Net Income Avl. to Common (TTM) | -584.90K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 37.96% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 51.72% | |||
| Balance Sheet | ACLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 76.00K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 148.20K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 8.91M | |||
| Current Ratio (Q) | 0.605 | |||
| Book Value Per Share (Q) | $0.12 | |||
| Total Assets (Q) | 9.22M | |||
| Total Current Liabilities (Q) | 244.90K | |||
| Total Debt (Q) | 90.20K | |||
| Total Liabilities (Q) | 309.90K | |||
| Total Common Equity (Q) | 8.91M | |||
| Cash Flow | ACLHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -315.10K | |||
| Cash from Financing (TTM) | 489.70K | |||
| Net Change in Cash (TTM) | -152.00K | |||
| Levered Free Cash Flow (TTM) | -765.00K | |||
| Cash from Operations (TTM) | -311.20K | |||
